DO CD34(+) CELL COUNTS PREDICT HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION (ABSCT)

被引：1
|
作者：
MIJOVIC, A
MUFTI, GJ
机构：
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1995年 / 89卷 / 01期
关键词：
D O I：
10.1111/j.1365-2141.1995.tb08939.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：226 / 227
页数：2
相关论文
共 50 条
  • [41] Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation
    Kaffenberger, Benjamin H.
    Wong, Henry K.
    Jarjour, Wael
    Andritsos, Leslie A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (03) : 489 - 492
  • [42] Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation
    Frère, P
    Pereira, M
    Fillet, G
    Beguin, Y
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (02) : 102 - 108
  • [43] Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery
    Remes, K
    Matinlauri, I
    Grenman, S
    Itala, M
    Kauppila, M
    Pelliniemi, TT
    Salminen, E
    Vanharanta, R
    Rajamaki, A
    JOURNAL OF HEMATOTHERAPY, 1997, 6 (01): : 13 - 19
  • [44] Relationship of CD34(+) cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation
    Kiss, JE
    Rybka, WB
    Winkelstein, A
    deMagalhaesSilverman, M
    Lister, J
    DAndrea, P
    Ball, ED
    BONE MARROW TRANSPLANTATION, 1997, 19 (04) : 303 - 310
  • [45] Selection and expansion of peripheral blood CD34(+) cells in autologous stem cell transplantation for breast cancer
    Williams, SF
    Lee, WJ
    Bender, JG
    Zimmerman, T
    Swinney, P
    Blake, M
    Carreon, J
    Schilling, M
    Smith, S
    Williams, DE
    Oldham, F
    VanEpps, D
    BLOOD, 1996, 87 (05) : 1687 - 1691
  • [46] Absence of a CD34− hematopoietic precursor population in recipients of CD34+ stem cell transplantation
    S Kato
    K Ando
    Y Nakamura
    Y Muguruma
    T Sato
    H Yabe
    M Yabe
    K Hattori
    Y Yasuda
    T Hotta
    Bone Marrow Transplantation, 2001, 28 : 587 - 595
  • [47] Relationship of CD 34+cell dose to hematopoietic recovery and transfusion requirements following autologous peripheral blood stem cell transplantation (PBSCT).
    Anguita, J
    Gómez-Pineda, A
    Ballesteros, M
    Serrano, D
    Diez-Martín, JL
    Pintado, T
    BLOOD, 1999, 94 (10) : 334B - 334B
  • [48] High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer
    Braunschweig, I
    Mirza, NQ
    Rondon, G
    Lauppe, J
    Mehra, R
    Gajewski, J
    Körbling, M
    Huh, YO
    Geisler, D
    Gee, AP
    Champlin, R
    Przepiorka, D
    CYTOTHERAPY, 2000, 2 (02) : 105 - 110
  • [49] Effects of CD34(+) selection and T cell immunodepletion on cord blood hematopoietic progenitors: Relevance to stem cell transplantation
    Laver, J
    Traycoff, CM
    AbdelMageed, A
    Gee, A
    Lee, C
    Turner, C
    Srour, EF
    Abboud, M
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (14) : 1492 - 1496
  • [50] Plerixafor approved for autologous hematopoietic stem-cell transplantation
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (02) : 112 - 112
12345